Free EpiPen Pricing Case Study Solution | Assignment Help

Harvard Case - EpiPen Pricing

"EpiPen Pricing" Harvard business case study is written by Michael Moffett. It deals with the challenges in the field of Strategy. The case study is 15 page(s) long and it was first published on : May 1, 2017

At Fern Fort University, we recommend Mylan implement a multi-pronged strategy to address the EpiPen pricing controversy, focusing on restoring public trust, enhancing value proposition, and fostering long-term sustainable growth. This strategy involves a combination of pricing adjustments, transparency initiatives, and strategic partnerships to ensure affordability and accessibility of this life-saving medication.

2. Background

The case study focuses on Mylan, a pharmaceutical company facing public backlash for the significant price increase of its EpiPen, an auto-injector for treating severe allergic reactions. The price hike, from $100 in 2007 to $600 in 2016, sparked public outrage, congressional investigations, and legal challenges. This situation highlights the ethical and strategic challenges faced by pharmaceutical companies when balancing profit maximization with social responsibility.

The main protagonists are Mylan CEO Heather Bresch, who faced intense scrutiny for her role in the price increase, and the public, who felt betrayed by the company's actions.

3. Analysis of the Case Study

Strategic Analysis:

  • Porter's Five Forces: The pharmaceutical industry is characterized by high barriers to entry (extensive research and development, regulatory hurdles), moderate supplier power (limited raw materials suppliers), moderate buyer power (limited substitutes, price sensitivity influenced by urgency), and high threat of substitutes (alternative treatments, generic competition).
  • SWOT Analysis:
    • Strengths: Strong brand recognition, established distribution network, market leader in epinephrine auto-injectors.
    • Weaknesses: Negative public perception, price sensitivity of customers, vulnerability to generic competition.
    • Opportunities: Expanding into emerging markets, developing innovative delivery systems, leveraging digital technology for patient engagement.
    • Threats: Increased regulatory scrutiny, generic competition, potential for disruptive innovation.
  • Value Chain Analysis: Mylan's value chain includes research and development, manufacturing, marketing and sales, and distribution. The price increase impacted the perceived value proposition, leading to customer dissatisfaction and reputational damage.
  • Business Model Innovation: Mylan needs to explore alternative business models, such as tiered pricing, value-based pricing, or subscription models, to ensure affordability and accessibility while maintaining profitability.

Financial Analysis:

  • Pricing Strategy: The price increase was driven by profit maximization, but it failed to consider the long-term implications on brand reputation and market share.
  • Financial Performance: While the price increase boosted revenue, it also led to negative publicity and potential legal challenges, impacting overall financial stability.

Marketing Analysis:

  • Brand Management: The EpiPen brand suffered significant damage due to the price increase, leading to a decline in consumer trust and loyalty.
  • Market Segmentation: Mylan needs to consider different market segments (patients, healthcare providers, insurers) and tailor pricing and communication strategies accordingly.

Operational Analysis:

  • Manufacturing Processes: Mylan needs to optimize manufacturing processes to ensure cost-efficiency and maintain consistent quality.
  • Supply Chain Management: A robust supply chain is crucial for ensuring timely availability of EpiPens, especially during emergencies.

Ethical Considerations:

  • Corporate Social Responsibility: Mylan needs to prioritize ethical considerations and demonstrate a commitment to social responsibility, particularly in the healthcare sector.
  • Transparency and Communication: Mylan should be transparent about pricing decisions and communicate effectively with stakeholders to build trust and address concerns.

4. Recommendations

  1. Price Adjustment: Implement a tiered pricing strategy based on patient income, insurance coverage, and geographic location. This ensures affordability for all while maintaining profitability.
  2. Transparency Initiative: Publish a detailed explanation of EpiPen pricing factors, including research and development costs, manufacturing expenses, and profit margins. This fosters transparency and builds trust with stakeholders.
  3. Strategic Partnerships: Collaborate with non-profit organizations, patient advocacy groups, and government agencies to provide financial assistance and access to EpiPens for underprivileged individuals and communities.
  4. Product Development: Invest in innovation and develop next-generation auto-injectors with improved features, such as longer shelf life, easier administration, and personalized dosage options. This strengthens the value proposition and enhances competitive advantage.
  5. Digital Transformation: Leverage digital technology to improve patient engagement, provide educational resources, and facilitate online ordering and delivery of EpiPens. This enhances accessibility and convenience for customers.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  1. Core Competencies and Consistency with Mission: Mylan's core competencies include research and development, manufacturing, and distribution. The recommendations align with these competencies while emphasizing ethical considerations and social responsibility, consistent with Mylan's mission.
  2. External Customers and Internal Clients: The recommendations address the needs of external customers (patients, healthcare providers, insurers) by ensuring affordability and accessibility, while also considering the needs of internal clients (employees, investors) by maintaining profitability and long-term sustainability.
  3. Competitors: The recommendations aim to strengthen Mylan's competitive position by fostering innovation, enhancing value proposition, and building a strong brand reputation.
  4. Attractiveness: The recommendations are expected to improve financial performance through increased market share, reduced legal risks, and enhanced brand value.

6. Conclusion

Mylan faces a critical juncture in its journey. By implementing these recommendations, the company can regain public trust, strengthen its competitive position, and ensure the long-term availability of this life-saving medication. This strategy emphasizes a balanced approach to profitability, social responsibility, and ethical business practices.

7. Discussion

Alternatives:

  • Maintaining current pricing: This option risks further damaging brand reputation and losing market share to competitors.
  • Aggressive price cuts: This could negatively impact profitability and limit investment in innovation.

Risks and Key Assumptions:

  • Regulatory changes: New regulations could impact pricing and distribution of EpiPens.
  • Generic competition: Increased generic competition could erode market share and profitability.
  • Public perception: Public perception may not change immediately despite efforts to improve transparency and affordability.

8. Next Steps

  1. Develop a detailed implementation plan: Outline specific actions, timelines, and responsible parties for each recommendation.
  2. Engage with stakeholders: Communicate the new pricing strategy and transparency initiatives to patients, healthcare providers, insurers, and government agencies.
  3. Monitor progress and adapt: Regularly assess the impact of the implemented strategy and make necessary adjustments based on market response and feedback.

By taking these steps, Mylan can navigate the current crisis and emerge as a leader in the pharmaceutical industry, committed to both profitability and social responsibility.

Hire an expert to write custom solution for HBR Strategy case study - EpiPen Pricing

Case Description

Mylan and it's CEO, Heather Bresch, were under attack for a multitude of large price increases in their life saving pharmaceutical, the EpiPen. The U.S. Congress, the Federal Drug Administration (FDA), and millions of people considered at risk and in need of access to EpiPen injectors, wanted to know why and how those price increases had happened.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - EpiPen Pricing

Hire an expert to write custom solution for HBR Strategy case study - EpiPen Pricing

EpiPen Pricing FAQ

What are the qualifications of the writers handling the "EpiPen Pricing" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " EpiPen Pricing ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The EpiPen Pricing case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for EpiPen Pricing. Where can I get it?

You can find the case study solution of the HBR case study "EpiPen Pricing" at Fern Fort University.

Can I Buy Case Study Solution for EpiPen Pricing & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "EpiPen Pricing" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my EpiPen Pricing solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - EpiPen Pricing

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "EpiPen Pricing" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "EpiPen Pricing"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study EpiPen Pricing to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for EpiPen Pricing ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the EpiPen Pricing case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "EpiPen Pricing" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Strategy case study - EpiPen Pricing




Referrences & Bibliography for Harvard Stategy Case Study Analysis & Solution

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.